Delaware recalls
3,429 federal recalls affecting Delaware in the last 12 months - 81 Delaware-specific plus 3,348 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov Women's Multivitamin Drops recalled for contamination risk
Wellnov Supplements LLC is recalling Liposomal Women's Liquid Multivitamin Drops with Iron due to manufacturing process deviations that could allow bacterial contamination, including potential botulism risk. The affected product was distributed nationwide between June 2025 and April 2026.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov Mens 50+ multivitamin drops recalled for bacterial risk
Wellnov Supplements LLC recalled Liposomal Mens 50+ Liquid Multivitamin Drops due to manufacturing issues that could allow harmful bacteria, including botulism-causing organisms, to contaminate the product. The 90 mL bottles were distributed nationwide and in Puerto Rico between June 2025 and April 2026.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov Mens multivitamin drops recalled for bacterial contamination risk
Wellnov Supplements' Liposomal Mens Liquid Multivitamin Drops may contain harmful bacteria, including potential C. botulinum, due to manufacturing practice violations. The product was distributed nationwide and in Puerto Rico between October 2024 and April 2026. No injuries have been reported.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov womens multivitamin drops recalled for bacterial contamination risk
Wellnov Supplements LLC is recalling Liposomal Womens 50+ Liquid Multivitamin Drops due to manufacturing deviations that could allow bacterial growth, including a possible risk of Clostridium botulinum contamination. The affected bottles were distributed nationwide and in Puerto Rico between October 2024 and April 2026.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov FulviLife Complex recalled for bacterial contamination risk
Wellnov Supplements' FulviLife Complex liquid supplement failed to meet manufacturing safety standards, which could allow harmful bacteria including botulism to grow in the product. The affected bottles were distributed nationwide and to Puerto Rico between October 2024 and April 2026.
- 2026-05-27FDA-FoodWellnov SupplementsClass IINationwideWellnov Joint Nourish recalled for bacterial contamination risk
Wellnov Supplements Joint Nourish liquid supplement was manufactured with deviations from required safety standards that could allow harmful bacteria, including those that cause botulism, to contaminate the product. About 90 bottles distributed nationwide between October 2025 and April 2026 may be affected.
- 2026-05-27FDA-DrugWisconsin PharmacalClass INationwideMG217 skin cream recalled for bacterial contamination
Wisconsin Pharmacal Company's MG217 Multi-Symptom Treatment Cream (colloidal oatmeal 2%, 6 oz) has been found to contain Staphylococcus aureus bacteria. The contamination was confirmed in lot #1024088 (expiration 11/30/2026). About 690 tubes were distributed nationwide and to the Bahamas.
- 2026-05-27FDA-DrugIntegraDoseClass IINationwideIntegraDose fentanyl citrate injection recalled for subpotency
IntegraDose Compounding Services LLC has recalled fentanyl citrate sterile injection (2,250 mcg/50 mL) because the drug may contain less active ingredient than labeled. This lot was distributed nationwide to healthcare facilities.
- 2026-05-27FDA-DrugUCB BiosciencesClass IINationwideCimzia prefilled syringes recalled for sterility concerns
UCB Biosciences is recalling specific lots of Cimzia (certolizumab pegol) 200 mg prefilled syringes because the manufacturer cannot confirm the product remained sterile during production. This is a precautionary recall; no infections or injuries have been reported so far.
- 2026-05-27FDA-DrugZydusClass IINationwideZydus erythromycin tablets recalled for nitrosamine impurity
Zydus Pharmaceuticals is recalling erythromycin 500 mg tablets because testing found a chemical impurity (N-Nitroso-Desmethyl-Erythromycin) at levels higher than FDA's recommended safe intake limit. The impurity resulted from manufacturing process deviations at the maker in India. No injuries have been reported.
- 2026-05-27FDA-DrugZydusClass IINationwideZydus erythromycin tablets recalled for nitrosamine impurity
Zydus Pharmaceuticals is recalling erythromycin tablets (250 mg) due to the presence of N-Nitroso-Desmethyl-Erythromycin, a nitrosamine impurity, at levels above the FDA's acceptable intake limit. The affected bottles were distributed nationwide. This impurity can potentially increase cancer risk with long-term exposure.
- 2026-05-27FDA-DrugANI PharmaceuticalsClass IINationwideANI Pharmaceuticals estradiol gel recalled for defective packets
ANI Pharmaceuticals is recalling estradiol gel (0.1%, 0.25 mg packets) because some packets in affected cartons were found to be empty or only partially filled. This could mean patients receive less medication than prescribed. The recall affects carton lot M251109, which expires in November 2027.
- 2026-05-27FDA-DrugHaleonClass IINationwideGas-X Simethicone recalled for incomplete ingredient labeling
Gas-X Simethicone 125 mg softgels distributed by Haleon are being recalled because the carton labeling does not list all inactive ingredients. This affects three specific lot codes (KB5Y, MP4B, and SS4F) distributed nationwide.
- 2026-05-27FDA-DrugLupinClass IINationwideLupin Liraglutide Injection recalled for particulate matter
Lupin Pharmaceuticals is recalling certain batches of Liraglutide Injection (a diabetes and weight-loss medication) because white thread-like particles have been found inside the cartridges. The affected pens are distributed nationwide. No injuries have been reported.
- 2026-05-27FDA-DrugSagent PharmaceuticalsClass IIINationwideSagent Busulfan Injection recalled for impurity specifications failure
Sagent Pharmaceuticals is recalling two lots of Busulfan Injection due to failed impurities and degradation specifications. The affected lots are 656412 (expiring 08/31/2026) and 659646 (expiring 03/31/2027). This is a prescription medication used in cancer treatment.
- 2026-05-27FDA-DrugAmerisourceClass IIINationwideAmerisource Primidone Tablets recalled for contamination
Amerisource Health Services has recalled certain batches of Primidone Tablets, USP, 50 mg due to cross-contamination during manufacturing. The tablets contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, which should not be present in this medication.
- 2026-05-27FDA-DrugAmerisourceClass IIINationwideAmerisource Primidone tablets recalled for cross-contamination
Primidone tablets distributed by American Health Packaging were found to contain trace amounts of Acemetacin, a different active pharmaceutical ingredient, due to cross-contamination during manufacturing. The affected lot (1027583, expiring 09/30/2027) contains approximately 63,500 tablets distributed nationwide. No injuries have been reported.
- 2026-05-27FDA-DrugGolden State Medical SupplyClass IIINationwideGolden State Medical Supply Primidone Tablets recalled for contamination
Golden State Medical Supply's Primidone Tablets (250 mg) contain trace amounts of Acemetacin, a different medication, due to cross-contamination during manufacturing. This affects two lots distributed nationwide. No injuries have been reported.
- 2026-05-27FDA-DrugGolden State Medical SupplyClass IIINationwideGolden State Medical Supply Primidone recalled for API contamination
Golden State Medical Supply is recalling Primidone 50 mg tablets because the active ingredient was contaminated with trace amounts of Acemetacin, a different medication. This contamination occurred during manufacturing. The affected bottles are identified by specific lot numbers with expiration dates in 2028.
- 2026-05-27FDA-DrugLannettClass IIINationwideLannett Primidone tablets recalled for API contamination
Lannett Company's Primidone Tablets 250mg were contaminated during manufacturing with trace amounts of Acemetacin, a different active pharmaceutical ingredient. The contamination affected specific lot numbers distributed nationwide. No injuries have been reported.
- 2026-05-26FDA-PROmnipodNationwideOmnipod insulin pods recalled for under-delivery risk
Insulet found a manufacturing issue in certain lots of Omnipod 5, Omnipod DASH, and Omnipod Eros pods that could cause insulin to leak instead of being fully delivered into the body. The leak occurs when a small tear develops in the tubing just above the skin. In some cases, users may not notice the problem, which can lead to high blood sugar levels and, in severe cases, diabetic ketoacidosis.
- 2026-05-26FDA-PRDexcom G7NationwideDexcom G7 sensors recalled after theft of scrapped product
Dexcom discovered that two lots of its G7 continuous glucose monitoring sensors—originally designated as scrap and scheduled for destruction—were stolen before being destroyed and sold by an unauthorized third party. One lot has an increased risk of skin infection due to improper sterilization; the other has an increased risk of sensor failure.
- 2026-05-25FDA-PRMogoNationwideMogo Moringa Capsules recalled for Salmonella risk
Mogo Moringa LLC is voluntarily recalling two specific lots of Mogo Moringa Oleifera Capsules due to a possible Salmonella contamination concern. The affected lots are Lot 15525AA (expires 06/2027) and Lot 00926AA (expires 01/2028). No Salmonella was detected in the company's own testing, but the recall is being issued as a precaution while the FDA continues its review.
- 2026-05-22FDA-PRRaaw EnergyRaaw Energy dog food recalled for Listeria risk
Raaw Energy is recalling multiple frozen dog food products produced between July 2025 and December 2025, plus one batch from March 31, 2026, due to possible Listeria monocytogenes contamination. Testing found some products positive for the bacteria. The company is taking precautions because not all products from the affected period were tested.
- 2026-05-21FDA-PRJXK EnterprisesNationwideBoner Bears Chocolate recalled for undeclared sildenafil
JXK Enterprises is recalling Boner Bears Chocolate (Lot #BB21125) because FDA testing found sildenafil, the active ingredient in prescription Viagra, in the product—but it was not listed on the label. Sildenafil can cause serious interactions with certain heart and blood pressure medications and poses health risks for people with diabetes, high blood pressure, or heart disease.
- 2026-05-21CPSCBethlehem LightsNationwideBethlehem Lights illuminated spheres recalled for fire hazard
The LED lights inside these decorative spheres can overheat and catch fire. The company has received nine reports of sparking or overheating, though no injuries have been reported so far.
- 2026-05-21CPSCABC TradingNationwideWSDZ light-up glasses recalled for battery ingestion risk
These LED shot glasses contain button cell batteries in an easily accessible compartment. Children can remove and swallow the batteries, which can cause serious internal burns and death. The glasses also lack required safety warnings.
- 2026-05-21CPSCPandaEarNationwidePandaEar hook-on chairs recalled for fall hazard
PandaEar portable hook-on chairs have a safety defect: the crotch restraints can be removed without tools, allowing infants to fall through an opening. This violates the mandatory safety standard for these products and poses a serious injury or death risk.
- 2026-05-21CPSCORB ToysNationwideOrb Funkee Squeeze Toys recalled for asbestos risk
ORB Toys' Funkee squeeze toys may contain asbestos-like fibers in the sand filling. If the toy ruptures or leaks, inhaling this dust could cause serious health problems. The recalled toys have date code 3102491A and were sold at Walmart and Ollie's Bargain Outlet between February 2025 and April 2026.
- 2026-05-21CPSCHomeProGymNationwideHomeProGym resistance bands recalled for separation hazard
HomeProGym-branded resistance bands can forcefully separate from the handle during use, creating a risk of serious impact injury. The recall affects only purple 60-pound and gray 70-pound bands sold in various sets and bundles between December 2025 and April 2026. No injuries have been reported so far.
Get notified about new Delaware recalls
Free weekly digest. Add Delaware to your profile to filter alerts to your state.
Get the Sunday Brief